A study to evaluate the efficacy of sublingual cannabinoid based medicineextract compared with placebo for the treatment of Insomnia.

Trial Profile

A study to evaluate the efficacy of sublingual cannabinoid based medicineextract compared with placebo for the treatment of Insomnia.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2018

At a glance

  • Drugs ZTL-101 (Primary)
  • Indications Insomnia
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jan 2018 Status changed from planning to not yet recruiting.
    • 18 Jan 2018 New trial record
    • 28 Nov 2017 Accordind to a Zelda Therapeutics media release, trial may start in the first quarter of 2018. Preliminary results from this trial is anticipated in third quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top